Abstract
In this paper, I discuss the dilemma of authenticity in ADHD subjectivity in the context of somatic, especially cerebral and neurochemical, personhood, which was stimulated by the rise of neuro-scientific knowledge, practices and technologies and their impact on culture and society. Through these processes, selfhood is continually identified with brainhood, in which mental processes are reduced to brain functions and neurochemistry. This has vast consequences on our understanding of human agency, morality and responsibility and opens existentialist questions about authenticity. In this sense, authenticity marks the effort to navigate the shifting relations of nature-culture and mind-brain and the uncertainty in conceptualisations of health, social functionality and normality. These dilemmas are practically significant in the case of subjectivities defined by psychiatric diagnosis in which the definition of authentic self impacts self-understanding and self-management of life strategies, such as treatment decisions.
Similar content being viewed by others
Data availability
Not applicable.
Notes
“Neuroexistentialism is what you get when Geisteswissenschaften reaches the stage where it finally and self-consciously exorcises the geist and recommends that no one should take seriously the Cartesian myth of the ghost in the machine”(Caruso and Flanagan 2017, s. 2).
References
Barkley, R. (1998). Attention-deficit hyperavitivity disorder. Scientific American.
Blum, K., A.L.-C. Chen, E.R. Braverman, D.E. Comings, T.J. Chen, V. Arcuri, S.H. Blum, B.W. Downs, R.L. Waite, and A. Notaro. 2008. Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Neuropsychiatric Disease and Treatment 4 (5): 893–918.
Bolt, I., and M. Schermer. 2009. Psychopharmaceutical enhancers: Enhancing identity? Neuroethics 2 (2): 103–111.
Breggin, P. 2007. Talking back to Ritalin: What doctors aren’t telling you about stimulants and ADHD. New York: Da Capo Press.
Breggin, P.R., and G.R. Breggin. 1996. The hazards of treating “attention-deficit/hyperactivity disorder” with methylphenidate (Ritalin). Journal of College Student Psychotherapy 10 (2): 55–72.
Caruso, G., and O. Flanagan. 2017. Neuroexistentialism: Meaning, morals, and purpose in the age of neuroscience. Oxford: Oxford University Press.
Chapman, R. 2019. Neurodiversity theory and its discontents: Autism, schizophrenia, and the social model of disability. In The Bloomsbury companion to philosophy of psychiatry, ed. Şerife Tekin and Robyn Bluhm, 371–390. London: Bloomsbury Academic.
Comstock, E.J. 2011. The end of drugging children: Toward the genealogy of the ADHD subject. Journal of the History of the Behavioral Sciences 47 (1): 44–69.
Conrad, P. 1976. Identifying hyperactive children: The medicalization of deviant behavior. Lexington: D. C. Heath.
Conrad, P., and D. Potter. 2000. From hyperactive children to ADHD adults: Observations on the expansion of medical categories. Social Problems 47 (4): 559–582.
DeGrazia, D. 2000. Prozac, enhancement, and self-creation. Hastings Center Report 30 (2): 34–40.
DeGrazia, D. 2005. Enhancement technologies and human identity. The Journal of Medicine and Philosophy 30 (3): 261–283.
Elliott, C. 2011. Enhancement technologies and the modern self. Journal of Medicine and Philosophy 36 (4): 364–374.
Erler, A., and T. Hope. 2014. Mental disorder and the concept of authenticity. Philosophy, Psychiatry, & Psychology 21 (3): 219–232.
Flanagan, O., and G. D. Caruso. 2018. Third wave existentialism. Neuroexistentialism: Meaning, Morals, and Purpose in the Age of Neuroscience 1–22.
Foucault, M. 2013. History of madness. London: Routledge.
Frankfurt, H.G. 1988. Freedom of the will and the concept of a person. In What is a person? Contemporary issues in biomedicine, ethics, and society, ed. M.F.Goodman. Clifton: Humana Press.
Fukuyama, F. 2003. Our posthuman future: Consequences of the biotechnology revolution. New York: Farrar, Straus and Giroux.
Gilroy, P. 2013. Between camps: Nations, cultures and the allure of race. London: Routledge.
Glannon, W. 2017. Behavior control, meaning, and neuroscience. In Neuroexistentialism: Meaning, morals, and purpose in the age of neuroscience, ed. Gregg D. Caruso and Owen Flanagan. New York: Oxford University Press.
Hacking, I. 2007. Kinds of People: Moving Targets. 151: 285.
Hallowell, E.M., and J.J. Ratey. 2011. Driven to distraction (revised): Recognizing and coping with attention deficit disorder. New York: Anchor.
Hoffman, G.A. 2019. ‘Aren’t mental disorders just chemical imbalances?’, ‘Aren’t mental disorders just brain dysfunctions?’, and other frequently asked questions about mental disorders. In The Bloomsbury companion to philosophy of psychiatry, ed. S. Tekin and R. Bluhm, 59–92. London: Bloomsbury Publishing.
Karp, D. A. 2007. Is it me or my meds?: Living with antidepressants. Harvard University Press.
Kramer, P.D., and P.D. Kramer. 1994. Listening to prozac. London: Fourth Estate.
Lakoff, A. 2000. Adaptive will: The evolution of attention deficit disorder. Journal of the History of the Behavioral Sciences 36 (2): 149–169.
Levy, N. 2011. Enhancing authenticity. Journal of Applied Philosophy 28 (3): 308–318.
Loe, M., and L. Cuttino. 2008. Grappling with the medicated self: The case of ADHD college students. Symbolic Interaction 31 (3): 303–323.
Mayes, R., and A. Rafalovich. 2007. Suffer the restless children: The evolution of ADHD and paediatric stimulant use, 1900–80. History of Psychiatry 18 (4): 435–457.
Novas, C., and N. Rose. 2000. Genetic risk and the birth of the somatic individual. Economy and Society 29 (4): 485–513.
Ortega, F. 2009. The cerebral subject and the challenge of neurodiversity. BioSocieties 4 (4): 425–445.
Parens, E. 2005. Authenticity and ambivalence: Toward understanding the enhancement debate. Hastings Center Report 35 (3): 34–41.
Richardson, K. 2018. Challenging sociality: An anthropology of robots, autism, and attachment. Cham: Springer.
Rose, N. 1999. Governing the soul: The shaping of the private self. London: Free Association.
Rose, N. 2001. The politics of life itself. Theory, Culture & Society 18 (6): 1–30.
Rose, N. 2003. The neurochemical self and its anomalies. In Risk and morality, ed. R. Ericson, 407–437. Toronto: University of Toronto Press.
Schechtman, M. 2004. Self-expression and self-control. Ratio 17 (4): 409–427.
Schermer, M. 2007. Brave new world versus island—Utopian and dystopian views on psychopharmacology. Medicine, Health Care and Philosophy 10: 119–128.
Singer, J. 2017. Neurodiversity: The birth of an idea. Edinburgh: University of Edinburgh.
Singh, I. 2005. Will the “real boy” please behave: Dosing dilemmas for parents of boys with ADHD. The American Journal of Bioethics 5 (3): 34–47.
Skinner, D. 2006. Racialized futures: Biologism and the changing politics of identity. Social Studies of Science 36 (3): 459–488.
Taylor, C. 1992. The ethics of authenticity. Cambridge: Harvard University Press.
Timimi, S. 2021. Insane medicine: How the mental health industry creates damaging treatment traps and how you can escape them. Indie Digital & Print Publishing.
Timimi, S., and J. Leo. 2009. Rethinking ADHD: From brain to culture. New York: Palgrave.
Vidal, F., and F. Ortega. 2017. Being brains. New York: Fordham University Press.
Walker, N. 2013. Throw away the master’s tools: Liberating ourselves from the pathology paradigm. Neuroqueer. https://neuroqueer.com/throw-away-the-masters-tools/
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Vrhel, A. Somatic personhood and the dilemma of authenticity in ADHD subjectivity. Subjectivity 30, 251–266 (2023). https://doi.org/10.1057/s41286-023-00165-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1057/s41286-023-00165-8